Observational studyThe British journal of ophthalmology2023

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.

Adrian Robert Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.